Haemonetics Corp. (HAE)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
Q2  2024 | |||||
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 6,074 | 0.01 | |
Q1  2024 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 6,074 | 0.01 | |
Q2  2020 | |||||
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 3,463 | 0.01 | |
Q1  2020 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 62.39% | 5,744 | 0.02 | |
Q4  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 9,207 | 0.02 | |
Q3  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 89,560 | 0.16 | |
Q2  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 89,560 | 0.16 | |
Q4  2018 | |||||
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 20,830 | 0.03 | |
Q3  2018 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 20,830 | 0.03 | |
Q2  2014 | |||||
≡ | Robert Olstein - Olstein Capital Management | Sell 100.00% | 11,000 | 0.06 | |
Q1  2014 | |||||
≡ | Robert Olstein - Olstein Capital Management | Buy | 11,000 | 0.06 | |
≡ | Meridian Contrarian Fund | Sell 100.00% | 279,700 | 1.59 | |
Q4  2013 | |||||
≡ | Meridian Contrarian Fund | Reduce 21.14% | 75,000 | 0.43 | |
Q3  2013 | |||||
≡ | Meridian Contrarian Fund | Reduce 19.29% | 84,800 | 0.48 | |
Q2  2013 | |||||
≡ | Meridian Contrarian Fund | Add 12.55% | 49,000 | 0.30 | |
Q1  2013 | |||||
≡ | Meridian Contrarian Fund | Add 10.12% | 35,900 | 0.22 | |
Q3  2012 | |||||
≡ | Meridian Contrarian Fund | Add 21.86% | 63,600 | 0.40 | |
Q2  2012 | |||||
≡ | Meridian Contrarian Fund | Buy | 291,000 | 1.70 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.